The genetics of venous and arterial thromboembolism
- 1 May 2001
- journal article
- review article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 3 (3) , 209-215
- https://doi.org/10.1007/s11883-001-0063-2
Abstract
There is substantial evidence to indicate that the pathologic processes of venous and arterial thromboembolism involve both genetic and environmental influences. Scientific progress over the past decade has revealed a growing number of genetic factors, such as factor V Leiden and the prothrombin gene variant, that are present in more than 1% of the population and increase the relative risk of venous thrombosis between two- and sevenfold. Furthermore, several of these factors have been demonstrated to interact adversely with environmental influences, such as oral contraceptives and smoking. Although these traits are present at relatively high prevalence in the population, the magnitude of the increased thrombotic risk associated with these factors is substantially less than that related to inherited deficiency of the natural anticoagulant protein antithrombin, and somewhat less than the elevated risk with protein C and protein S deficiencies. In contrast to the progress that has been made in understanding the genetic contributions to venous thromboembolism, much still remains to be learned about the genetic basis of arterial thrombosis. Despite the documentation of associations between several genetic polymorphisms with plasma procoagulant levels, consistent associations with arterial thrombotic disease have not been found.Keywords
This publication has 70 references indexed in Scilit:
- Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetesKidney International, 2000
- The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationNew England Journal of Medicine, 1999
- Born to clot: the European burdenBritish Journal of Haematology, 1999
- A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.Journal of Clinical Investigation, 1997
- Two Mutations in the Promoter Region of the Human Protein C Gene Both Cause Type I Protein C Deficiency by Disruption of Two HNF-3 Binding SitesPublished by Elsevier ,1995
- Genotypic Variation in the Promoter Region of the Protein C Gene Is Associated With Plasma Protein C Levels and Thrombotic RiskArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Homozygous protein S deficiency in an infant with purpura fulminansThe Journal of Pediatrics, 1990
- The human protein S locus: Identification of the PSα gene as a site of liver protein S messenger RNA synthesisBiochemical and Biophysical Research Communications, 1988
- Deficiency of protein C in congenital thrombotic disease.Journal of Clinical Investigation, 1981